Ray E. Peck
Chief Executive Officer
With over 25 years’ experience in front line business development, as well as sales management, Ray has worked in over a dozen countries, and on almost every continent. He is multi-lingual, and has worked with Global “Big Pharma” clients, as well as with the entrepreneurs at small virtual companies. He has held positions of increasing responsibility including Director of North American and European – Pharma/Biotech Business Development, Director of Global Strategic Accounts at Azopharma, Executive Director at CoreRx Pharma Services, and most recently as Founder and CEO of CRO Solutions. Ray’s focus has been in drug development services from discovery chemistry, to clinical trial materials, and to niche commercial manufacturing, including both small molecule and large molecule programs. Ray founded CRO Solutions/VxP Biologics in 2010, which has since grown to include contract labs on several continents, and in almost every area of drug development. Ray holds a BS from Michigan State.
Chief Financial Officer
Ms. Keepper has over 25 years’ experience in management, accounting and finance. She received her BS in Accounting and Finance from Lipscomb University in Nashville, TN, and went on to earn her CPA. Kim spent seven years at KPMG, where she served in multiple roles, including Audit Manager over several large publicly traded companies. Kim spent four years in Japan working on the AAFES Management Team, and continued on for three years in positions of increasing responsibility in the United States. In 2002, Kim joined Renal Care Group, a kidney dialysis company, as Regional Controller. In 2008, Kim became Revenue Controller at Fresenius Medical Care, the largest kidney dialysis company in the United States, and one of the largest in the world. Kim has served as our Chief Financial Officer since 2010.
Patti Day, BSN RN CCRC
Director of Operations
Patti brings 15 years of clinical trial experience from both the corporate and academic sectors. She has managed investigational drug trials in a variety of therapeutic areas, including dermatology, immunology, rheumatology, endocrinology, and oncology. She received her BSN from Indiana University in 2001. Her research career began as a coordinator at Indiana University School of Medicine. She then moved to the private sector to focus on project management, effectively earning her Lean Six Sigma Yellow Belt for Public Health from Purdue HealthcareTAP in 2011. Patti earned her certification as a Clinical Research Professional from ACRP in 2013. Through her site-level work on various novel therapies for chemotherapy-induced anemia, small cell lung cancer, mesothelioma, psoriasis and atopic dermatitis, she has built strong relationships with numerous pharmaceutical and CRO partners. In December, 2014, she became Director of Research at Dawes Fretzin Clinical Research Group where she was responsible for the successful execution of over 50 industry-sponsored, Phase IIa-IV trials. Patti joined VxP in March of 2016.